| Literature DB >> 20625487 |
Arzucan Ozgür1, Zuoshuang Xiang, Dragomir R Radev, Yongqun He.
Abstract
Interferon-gamma (IFN-gamma) regulates various immune responses that are often critical for vaccine-induced protection. In order to annotate the IFN-gamma-related gene interaction network from a large amount of IFN-gamma research reported in the literature, a literature-based discovery approach was applied with a combination of natural language processing (NLP) and network centrality analysis. The interaction network of human IFN-gamma (Gene symbol: IFNG) and its vaccine-specific subnetwork were automatically extracted using abstracts from all articles in PubMed. Four network centrality metrics were further calculated to rank the genes in the constructed networks. The resulting generic IFNG network contains 1060 genes and 26313 interactions among these genes. The vaccine-specific subnetwork contains 102 genes and 154 interactions. Fifty six genes such as TNF, NFKB1, IL2, IL6, and MAPK8 were ranked among the top 25 by at least one of the centrality methods in one or both networks. Gene enrichment analysis indicated that these genes were classified in various immune mechanisms such as response to extracellular stimulus, lymphocyte activation, and regulation of apoptosis. Literature evidence was manually curated for the IFN-gamma relatedness of 56 genes and vaccine development relatedness for 52 genes. This study also generated many new hypotheses worth further experimental studies.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20625487 PMCID: PMC2896678 DOI: 10.1155/2010/426479
Source DB: PubMed Journal: J Biomed Biotechnol ISSN: 1110-7243
Figure 1Description of the literature-based discovery system for identifying IFN-γ and vaccine-related genes.
Figure 2Gene name normalization example.
Figure 3The dependency parse tree of the sentence “IL-2 and IL-15 induced the production of IL-17 and IFN-γ in a dose dependent manner by PBMCs.”
Figure 4Summary of the IFNG network and its vaccine-specific subnetwork.
Figure 5The graph of the IFNG-vaccine network extracted from the literature. The network consists of 102 nodes (genes) and 154 edges (interactions). All the edges in the network are associated with the term “vaccine” and its variants. The purple nodes are the genes that are central in both the generic and the IFNG-vaccine networks. The red nodes are the genes that are central only in the IFNG-vaccine network. The green nodes are the genes that are central only in the generic IFNG network. The rest of the nodes are shown in yellow.
Predicted 56 genes related to IFN-γ and vaccine networks.
| Gene | Generic IFNG Network | IFNG-vaccine Network | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| D | E | B | C | IFNG-Ref | D | E | B | C | Vaccine-Ref | |
| TNF | 1 | 1 | 1 | 1 | 3132506 | 2 | 3 | 2 | 7 | 16446013 |
| NFKB1 | 2 | 2 | 2 | 2 | 9888423 | — | 23 | — | — | 16971487 |
| IL6 | 3 | 3 | 3 | 3 | 1719090 | 3 | 4 | 7 | 3 | 10225849 |
| IL8 | 4 | 5 | 6 | 4 | 8473010 | 10 | 13 | 10 | 9 | 11378044 |
| IL10 | 5 | 4 | 4 | 5 | 8102388 | 6 | 8 | 11 | 2 | 10930151 |
| IL4 | 6 | 6 | 5 | 6 | 2136895 | 4 | 2 | 4 | 4 | 8519092 |
| MAPK1 | 7 | 9 | 9 | 7 | 15307176 | — | — | — | — | 19428911 |
| IL2 | 8 | 7 | 8 | 8 | 6429853 | 1 | 1 | 1 | 1 | 8459207 |
| VEGFA* | 9 | 10 | 10 | 9 | 12816689 | — | — | — | — | 17502972 |
| TP53* | 10 | 8 | 7 | 10 | 16391798 | — | — | — | — | 18846387 |
| BCL2* | 11 | 13 | 13 | 11 | 11064392 | — | — | — | — | 19389797 |
| AKT1* | 12 | 11 | 12 | 12 | 11135576 | — | — | — | — | 19107122 |
| MAPK8 | 13 | 14 | 14 | 13 | 18950753 | — | — | 15 | — | 19428911 |
| INS | 14 | 12 | 11 | 14 | 8383325 | — | — | — | 16 | 19203100 |
| MAPK14 | 15 | 15 | 18 | 15 | 10700460 | — | — | — | — | 19428911 |
| CSF2 | 16 | 18 | 17 | 16 | 11665752 | 7 | 6 | 6 | 6 | 19459853 |
| FAS | 17 | 17 | 16 | 17 | 10895367 | — | — | — | — | 15979942 |
| CCL2 | 18 | 19 | 19 | 18 | 9407497 | — | — | — | — | 19833737 |
| IFNA1 | 19 | 16 | 15 | 19 | 11449378 | — | — | — | 13 | 19667099 |
| EGFR* | 20 | 20 | 23 | 20 | 17362940 | — | — | — | — | 19178753 |
| JUND* | 21 | 21 | 22 | 21 | 10070035 | — | — | — | — | 19124729 |
| KITLG* | 22 | 24 | — | 22 | 7540064 | — | — | — | — | - |
| CCL5 | 23 | 23 | 21 | 23 | 8921438 | — | 24 | — | — | 15827150 |
| CD4 | 24 | 22 | 20 | 24 | 15173593 | 9 | 5 | 3 | 12 | 17298856 |
| EGF* | 25 | 25 | — | 25 | 18160214 | — | — | — | — | 16357522 |
| CRP | — | — | 24 | — | 10675363 | — | — | — | — | 16395099 |
| STAT3* | — | — | 25 | — | 7488223 | — | — | — | — | - |
| IL5 | — | — | — | — | 9432015 | 5 | 7 | 20 | 8 | 11138639 |
| IL13 | — | — | — | — | 12670721 | 8 | 9 | 5 | 5 | 12232042 |
| IL7 | — | — | — | — | 7594482 | 11 | 14 | 12 | 17 | 17496983 |
| EIF2AK2 | — | — | — | — | 11342638 | 12 | 10 | 8 | — | 19596385 |
| CD28 | — | — | — | — | 7634349 | 13 | 12 | — | — | 12594842 |
| HSPD1 | — | — | — | — | 12407015 | 14 | 19 | 16 | 14 | 12218165 |
| SILV | — | — | — | — | 11839572 | 15 | 20 | 17 | 23 | 11459172 |
| IL21 | — | — | — | — | 14657853 | 16 | 17 | — | — | 16785513 |
| IL18 | — | — | — | — | 8666798 | 17 | — | — | 10 | 19467215 |
| HBEGF | — | — | — | — | 9062364 | 18 | 25 | — | 21 | 10729731 |
| CD46 | — | — | — | — | 15307176 | 19 | 11 | 9 | — | 11757799 |
| CD40 | — | — | — | — | 7554483 | 20 | 16 | — | — | 11403919 |
| PSG2 | — | — | — | — | 2516715 | 21 | — | 22 | — | 11155821 |
| GAD1 | — | — | — | — | 9703171 | 22 | — | — | 18 | 12421990 |
| IL15 | — | — | — | — | 9834271 | 23 | — | — | 22 | 16785513 |
| C3 | — | — | — | — | 1337336 | 24 | 15 | — | — | 19477524 |
| PRF1 | — | — | — | — | 19651871 | 25 | 22 | 19 | — | 15214037 |
| ZAP70 | — | — | — | — | 11034358 | — | 18 | 23 | — | — |
| CD40LG | — | — | — | — | 10769003 | — | 21 | 18 | — | 11403919 |
| GNLY | — | — | — | — | 17382591 | — | — | 13 | 19 | 10644038 |
| PTPN11 | — | — | — | — | 12270932 | — | — | 14 | — | — |
| CD86 | — | — | — | — | 9836505 | — | — | 21 | — | 12594842 |
| CCR5 | — | — | — | — | 9616137 | — | — | 24 | — | 16672545 |
| HSPA4 | — | — | — | — | 18442794 | — | — | 25 | — | 11779704 |
| TPBG | — | — | — | — | 16630022 | — | — | — | 11 | 16630022 |
| KLK3 | — | — | — | — | 16000955 | — | — | — | 15 | 19171173 |
| CD8A | — | — | — | — | 1904117 | — | — | — | 20 | 18425263 |
| CD80 | — | — | — | — | 7537534 | — | — | — | 24 | 10498243 |
| LTA | — | — | — | — | 3102976 | — | — | — | 25 | 15908422 |
Note: The genes ranked among the top 25 by the centrality measures (D: Degree; E: Eigenvector; B: Betweenness; C: Closeness) in the generic IFNG network or the IFNG-vaccine network. The genes are represented with their official HGNC symbols. Literature evidences for the relatedness of the genes to IFNG (IFNG-Ref) and to vaccine development (Vaccine-Ref) are manually curated. “—” indicates that the gene is not ranked among the top 25 by the corresponding centrality measure in the corresponding network or no literature evidence was found.
Figure 6Interactions of MAPK8 with other genes in the generic IFNG network. MAPK8 is shown in purple. The two genes (ZAP70 and EIF2AK2) that MAPK8 also interacts in the IFNG-vaccine network are shown in red.
Gene annotation enrichment among top predicted genes in the generic IFNG and the IFNG-vaccine networks.
| Category | Term | Count | FDR | |
|---|---|---|---|---|
| GOTERM_BP_ALL | GO:0050896~response to stimulus | 43 | 2.99 | 5.71 |
| GOTERM_BP_ALL | GO:0007154~cell communication | 39 | 5.74 | 1.10 |
| GOTERM_BP_ALL | GO:0007165~signal transduction | 35 | 9.70 | 1.86 |
| GOTERM_BP_ALL | GO:0006950~response to stress | 29 | 7.14 | 1.37 |
| GOTERM_BP_ALL | GO:0030154~cell differentiation | 28 | 6.94 | 1.33 |
| GOTERM_BP_ALL | GO:0006952~defense response | 26 | 7.12 | 1.36 |
| GOTERM_BP_ALL | GO:0006955~immune response | 26 | 8.88 | 1.70 |
| GOTERM_BP_ALL | GO:0008283~cell proliferation | 23 | 9.37 | 1.70 |
| GOTERM_BP_ALL | GO:0008219~cell death | 23 | 2.28 | 4.46 |
| GOTERM_BP_ALL | GO:0006915~apoptosis | 22 | 9.38 | 1.78 |
| GOTERM_BP_ALL | GO:0007242~intracellular signaling cascade | 19 | 4.85 | 9.27 |
| GOTERM_BP_ALL | GO:0001775~cell activation | 18 | 5.86 | 1.12 |
| GOTERM_BP_ALL | GO:0006954~inflammatory response | 17 | 8.26 | 1.49 |
| GOTERM_BP_ALL | GO:0046649~lymphocyte activation | 14 | 1.77 | 3.38 |
| GOTERM_BP_ALL | GO:0006468~protein amino acid phosphorylation | 14 | 2.60 | 4.98 |
| GOTERM_BP_ALL | GO:0006807~nitrogen compound metabolic process | 13 | 4.47 | 8.56 |
| GOTERM_BP_ALL | GO:0042110~T cell activation | 12 | 9.02 | 1.73 |
| GOTERM_BP_ALL | GO:0048534~hemopoietic or lymphoid organ development | 12 | 4.57 | 8.74 |
| GOTERM_CC_ALL | GO:0005576~extracellular region | 29 | 5.33 | 8.27 |
| GOTERM_MF_ALL | GO:0005125~cytokine activity | 19 | 5.30 | 9.51 |
| GOTERM_MF_ALL | GO:0008083~growth factor activity | 12 | 6.77 | 1.21 |
| KEGG_PATHWAY | hsa04060:Cytokine-cytokine receptor interaction | 23 | 7.90 | 9.77 |
| KEGG_PATHWAY | hsa04620:Toll-like receptor signaling pathway | 13 | 3.12 | 3.91 |
| KEGG_PATHWAY | hsa04660:T cell receptor signaling pathway | 12 | 2.04 | 2.57 |
| KEGG_PATHWAY | hsa04630:Jak-STAT signaling pathway | 11 | 2.99 | 0.003745 |